Literature DB >> 17132655

IMBA Professional Plus: a flexible approach to internal dosimetry.

A Birchall1, M Puncher, J W Marsh, K Davis, M R Bailey, N S Jarvis, A D Peach, M-D Dorrian, A C James.   

Abstract

IMBA (Integrated Modules for Bioassay Analysis) is a suite of software modules that implement the current ICRP biokinetic and dosimetric models for estimation of intakes and doses. The IMBA modules have gone through extensive quality assurance, and are now used for routine formal dose assessment by Approved Dosimetry Services throughout the UK. HPA has continued to develop the IMBA modules. In addition, several projects, sponsored by organisations both in the USA and in Canada, have resulted in the development of customised user-friendly interfaces (IMBA Expert 'editions'). These enable users not only to use the standard ICRP models, but also to change many of the parameter values from ICRP defaults, and to apply sophisticated data handling techniques to internal dose calculations. These include: fitting measurement data with the maximum likelihood method; using multiple chronic and acute intakes; and dealing with different data types, such as urine, faces and whole body simultaneously. These interfaces were improved further as a result of user-feedback, and a general 'off-the-shelf' product, IMBA Professional, was developed and made available in January 2004. A new version, IMBA Professional Plus, was released in April 2005, which is both faster and more powerful than previous software. The aim of this paper is to describe the capabilities of IMBA Professional Plus, and the mathematical methods used.

Entities:  

Mesh:

Year:  2006        PMID: 17132655     DOI: 10.1093/rpd/ncl171

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  8 in total

1.  Microdistribution and long-term retention of 239Pu (NO3)4 in the respiratory tracts of an acutely exposed plutonium worker and experimental beagle dogs.

Authors:  Christopher E Nielsen; Dulaney A Wilson; Antone L Brooks; Stacey L McCord; Gerald E Dagle; Anthony C James; Sergei Y Tolmachev; Brian D Thrall; William F Morgan
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

2.  A comparison of thyroidal protection by iodine and perchlorate against radioiodine exposure in Caucasians and Japanese.

Authors:  A Rump; S Eder; C Hermann; A Lamkowski; M Kinoshita; T Yamamoto; M Abend; N Shinomiya; M Port
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

3.  THE MAYAK WORKER DOSIMETRY SYSTEM (MWDS-2013): AN INTRODUCTION TO THE DOCUMENTATION.

Authors:  B A Napier
Journal:  Radiat Prot Dosimetry       Date:  2017-11-01       Impact factor: 0.972

4.  Preparing for a "dirty bomb" attack: the optimum mix of medical countermeasure resources.

Authors:  Alexis Rump; Patrick Ostheim; Stefan Eder; Cornelius Hermann; Michael Abend; Matthias Port
Journal:  Mil Med Res       Date:  2021-01-17

5.  Simulations of radioiodine exposure and protective thyroid blocking in a new biokinetic model of the mother-fetus unit at different pregnancy ages.

Authors:  A Rump; C Hermann; A Lamkowski; M Abend; M Port
Journal:  Arch Toxicol       Date:  2022-08-04       Impact factor: 6.168

6.  Uranium Aerosol Activity Size Distributions at a Nuclear Fuel Fabrication Plant.

Authors:  Edvin Hansson; Håkan B L Pettersson; Mats Eriksson
Journal:  Health Phys       Date:  2020-09       Impact factor: 2.922

7.  Plutonium in Manhattan Project workers: Using autopsy data to evaluate organ content and dose estimates based on urine bioassay with implications for radiation epidemiology.

Authors:  Martin Šefl; Joey Y Zhou; Maia Avtandilashvili; Stacey L McComish; Sergei Y Tolmachev
Journal:  PLoS One       Date:  2021-10-26       Impact factor: 3.240

8.  Estimation of radiation-induced health hazards from a "dirty bomb" attack with radiocesium under different assault and rescue conditions.

Authors:  Alexis Rump; Stefan Eder; Cornelius Hermann; Andreas Lamkowski; Patrick Ostheim; Michael Abend; Matthias Port
Journal:  Mil Med Res       Date:  2021-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.